Colgate-Palmolive (NYSE:CL) was the recipient of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 13,220,000 shares, a growth of 5.5% from the September 30th total of 12,530,000 shares. Based on an average daily trading volume, of 3,380,000 shares, the short-interest ratio is currently 3.9 days. Approximately 1.6% of the company’s stock are short sold.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
Several research firms have recently weighed in on CL. Bank of America dropped their target price on shares of Colgate-Palmolive from $82.00 to $77.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $70.00 price objective for the company. in a research report on Monday, November 4th. Citigroup boosted their price objective on shares of Colgate-Palmolive from $77.00 to $79.00 and gave the company a “neutral” rating in a research report on Tuesday, August 20th. ValuEngine raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Thursday, November 14th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $76.00 to $71.00 and set a “neutral” rating for the company in a research note on Monday, November 4th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $72.57.
In other news, Chairman Ian M. Cook sold 19,500 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $73.97, for a total value of $1,442,415.00. Following the completion of the sale, the chairman now owns 1,088,367 shares of the company’s stock, valued at approximately $80,506,506.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Prabha Parameswaran sold 4,221 shares of the business’s stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $71.68, for a total transaction of $302,561.28. Following the completion of the sale, the insider now directly owns 16,793 shares of the company’s stock, valued at approximately $1,203,722.24. The disclosure for this sale can be found here. Insiders have sold a total of 115,486 shares of company stock worth $8,119,050 in the last ninety days. 1.14% of the stock is currently owned by insiders.
Large investors have recently modified their holdings of the company. Krane Funds Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter worth approximately $25,000. Julex Capital Management LLC acquired a new stake in Colgate-Palmolive during the third quarter valued at approximately $27,000. Lipe & Dalton acquired a new stake in Colgate-Palmolive during the second quarter valued at approximately $29,000. Quest Capital Management Inc. ADV acquired a new stake in Colgate-Palmolive during the third quarter valued at approximately $31,000. Finally, Horan Capital Advisors LLC. acquired a new stake in Colgate-Palmolive during the third quarter valued at approximately $32,000. 76.90% of the stock is owned by institutional investors.
Colgate-Palmolive stock traded down $0.08 during midday trading on Monday, reaching $66.63. 9,003 shares of the stock traded hands, compared to its average volume of 4,047,775. The company has a current ratio of 1.03, a quick ratio of 0.70 and a debt-to-equity ratio of 43.94. The firm has a fifty day moving average price of $68.17 and a two-hundred day moving average price of $71.32. The firm has a market cap of $57.21 billion, a price-to-earnings ratio of 22.40, a PEG ratio of 5.30 and a beta of 0.73. Colgate-Palmolive has a fifty-two week low of $57.51 and a fifty-two week high of $76.41.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.71 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.01. The company had revenue of $3.93 billion during the quarter, compared to analyst estimates of $3.95 billion. Colgate-Palmolive had a net margin of 15.04% and a return on equity of 6,492.71%. The business’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.72 EPS. Analysts anticipate that Colgate-Palmolive will post 2.83 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.58%. The ex-dividend date of this dividend was Tuesday, October 22nd. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
See Also: Why do earnings reports matter?